The Valley Desk

NCT03586999 · Interventional trial

Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas

Overall registry status Completed

Phase 1 · Phase 2

Conditions Peripheral T Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov